Iterum Therapeutics Plc

NASDAQ:ITRM   3:59:36 PM EDT
0.80
-0.02 (-2.84%)
5:06:58 PM EDT: $0.76 -0.04 (-4.48%)
Earnings Announcements

Iterum Therapeutics Reports Third Quarter 2020 Financial Results

Published: 11/16/2020 11:53 GMT
Iterum Therapeutics PLC (ITRM) - Iterum Therapeutics Reports Third Quarter 2020 Financial Results.
Iterum Therapeutics Plc Qtrly Loss per Share $0.60.
Iterum Therapeutics Plc - As of September 30, 2020, Co Had Cash and Cash Equivalents of $8.6 Million.
Iterum Therapeutics Plc - Will Be Able to Fund Its Operations Into Q3 of 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.18

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.21

More details on our Analysts Page.